BIOTON S.A. (WSE:BIO)
Poland
· Delayed Price · Currency is PLN 4.200
+0.020 (0.48%)
May 30, 2025, 5:03 PM CET
BIOTON Revenue
BIOTON had revenue of 65.62M PLN in the quarter ending March 31, 2025, with 75.06% growth. This brings the company's revenue in the last twelve months to 235.90M, up 27.69% year-over-year. In the year 2024, BIOTON had annual revenue of 207.76M with 14.38% growth.
Revenue (ttm)
235.90M
Revenue Growth
+27.69%
P/S Ratio
1.53
Revenue / Employee
649.86K
Employees
364
Market Cap
360.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 207.76M | 26.13M | 14.38% |
| Dec 31, 2023 | 181.64M | -51.52M | -22.10% |
| Dec 31, 2022 | 233.16M | 70.13M | 43.01% |
| Dec 31, 2021 | 163.03M | -58.75M | -26.49% |
| Dec 31, 2020 | 221.79M | 19.76M | 9.78% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 12.82B |
| Synektik Spólka Akcyjna | 556.63M |
| Voxel | 556.98M |
| Celon Pharma | 213.98M |
| Ryvu Therapeutics | 97.57M |
| Selvita | 359.79M |
| Centrum Medyczne ENEL-MED | 735.59M |
| EMC Instytut Medyczny | 809.41M |